Damaged Progenitors as Targets for Breast Cancer Prevention

Abstract

Moving new breast cancer prevention approaches forward into clinical trials requires robust data supporting both mechanism and efficacy. Our Breakthrough-funded study identified early changes in the breast cancer cell-of-origin. Here, we seek to understand these changes and the unique cell sensitivities they create, as a means of revealing new and unanticipated targets for breast cancer prevention. Our objectives are to unravel the mechanisms that give rise to the damaged cells and to reveal specific methods for eliminating them, thereby laying the groundwork for clinical trials of novel breast cancer prevention approaches.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2021
Accession Number
AD1156247

Entities

People

  • Leif W Ellisen

Tags

DTIC Thesaurus Topics

  • Biomedical Research
  • Breast Cancer
  • Cells
  • Clinical Trials
  • Epithelial Cells
  • Gene Expression
  • Genes
  • Genetics
  • Health Care
  • Health Services
  • Hospitals
  • Inhibitors
  • Neoplasms
  • Rna Sequence Analysis
  • Technology Transfer
  • Tissues
  • Vulnerability

Fields of Study

  • Physics

Readers

  • Molecular and genetic basis of cancer.
  • Oncology (Cancer Research).